Publication | Open Access
Efficacy and Safety of the Hedgehog Pathway Inhibitor Vismodegib in Patients with Advanced Basal Cell Carcinoma (BCC): 12-Month Erivance BCC Study Update
11
Citations
0
References
2012
Year
MedicinePathologyAnti-cancer AgentDermatologyCancer TreatmentOncologyCancer ResearchTumor BiologySkin Cancer
No additional data available for this publication yet. Check back later!